Irene Chang, MD
Pediatric Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 3
- Since medical school
- 12 years
- Graduated 2014
Offices
3 locations · UCSF Pediatrics Associates · University of California San Francisco
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
State licence records
1 licence
- Washington MD.MD.60654898Physician And Surgeon License · since 2016 · expires 2026-06-08ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$3,706
Medicare paid this office $3,706 for 15 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 11 | $1,686 | $112 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $1,222 | $27 |
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 56 · 85 and older 0% · Health risk score 1.86. Above the middle of the specialty; the typical pediatric medicine clinician is at 1.4.
The office billed $24,380, Medicare allowed $5,031 and paid $3,706; for 66 services of 3 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$20,933 in 2024
Medicaid paid $20,933 for 202 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 83 | $14,928 |
| Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service) | 60 | $5,317 |
| Telehealth transmission, per minute, professional services bill separately | 59 | $689 |
| 2024 | 202 | 3 | 22 | $20,933 |
| 2023 | 32 | 2 | 19 | $1,800 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 13 | $1,591 |
| Telehealth transmission, per minute, professional services bill separately | 19 | $209 |
Drugs they prescribed that Part D paid
$1,590,399
Pharmacies billed $1,590,399 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 47) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
0 generic and 40 brand-name prescriptions · $1,590,399 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dojolvi | 13 | $116,129 | $8,933 |
Year by year
| 2024 | 47 | None | 0% (0) | 85% | $1,590,399 |
| 2023 | 23 | None | 0% (0) | None | $139,377 |
| 2022 | 18 | None | 0% (0) | 78% | $42,655 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Cystadane | 11 | $42,191 | $3,836 |
Money from drug and device companies
$9,587 in 2025
| 2025 | 4 | 7 | $9,500 | $9,587 |
| 2024 | 1 | 1 | None | $38 |
| 2021 | 1 | 1 | None | $30 |
| 2019 | 1 | 1 | None | $38 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| BioMarin Pharmaceutical | None | $5,475 | 4 payments
|
| Chiesi USA | Elfabrio | $4,025 | 1 payment
|
| Stryker | Na | $69 | 1 payment
|
| Avita Medical Americas | Permeaderm | $19 | 1 payment
|
See all 7 published payments
| BioMarin Pharmaceutical | Consulting · 2025-12-31 | None | $1,369 |
| BioMarin Pharmaceutical | Consulting · 2025-12-31 | None | $1,369 |
| BioMarin Pharmaceutical | Consulting · 2025-12-31 | None | $1,369 |
| BioMarin Pharmaceutical | Consulting · 2025-12-31 | None | $1,369 |
| Stryker | Meals · 2025-08-05 | Na | $69 |
| Avita Medical Americas | Meals · 2025-07-29 | Permeaderm | $19 |
| Chiesi USA | Paid to speak or teach · 2025-06-05 | Elfabrio | $4,025 |
See earlier years (2024, 2021, 2019)
2024: $38
| BioMarin Pharmaceutical | None | $38 | 1 payment
|
2021: $30
| Ultragenyx Pharmaceutical | Dojolvi | $30 | 1 payment
|
2019: $38
| BioMarin Pharmaceutical | None | $38 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| GENZYME CORPORATION · Dfi-Phase 1/2 Dose Esc & Exp Study of Sar444836 (Gene Therapy) in Pts. W/Phenlyketonuria · 2025 | Their institution | $75,659 |
| Ultragenyx Pharmaceutical Inc. · Ux007-Cl401 · 2024 | Their institution | $57,487 |
| Ultragenyx Pharmaceutical Inc. · Ux007-Cl401 · 2025 | Their institution | $40,296 |
| SANOFI US SERVICES INC. · Fabry Disease Registry Protocol · 2025 | Their institution | $8,213 |
| SANOFI US SERVICES INC. · Fabry Disease Registry Protocol · 2024 | Their institution | $7,461 |
| BioMarin Pharmaceutical Inc. · Cerliponase Alfa Observational Study US) · 2022 | Their institution | $7,112 |
| BioMarin Pharmaceutical Inc. · Cerliponase Alfa Observational Study US) · 2021 | Their institution | $5,000 |
| SANOFI US SERVICES INC. · Pompe Disease Registry · 2023 | Their institution | $4,775 |
| BioMarin Pharmaceutical Inc. · Cerliponase Alfa Observational Study (US) · 2024 | Their institution | $4,281 |
| BioMarin Pharmaceutical Inc. · Cerliponase Alfa Observational Study (US) · 2023 | Their institution | $2,590 |
| SANOFI US SERVICES INC. · Dfi-Phase 1/2 Dose Esc & Exp Study of Sar444836 (Gene Therapy) in Pts. W/Phenlyketonuria · 2024 | This clinician | $2,378 |
| SANOFI US SERVICES INC. · Fabry Disease Registry Protocol · 2023 | Their institution | $1,675 |
| SANOFI US SERVICES INC. · Mucopolysaccharidosis I (Mps I) Registry · 2023 | Their institution | $1,550 |
| SANOFI US SERVICES INC. · Gaucher Disease Registry Protocol · 2023 | Their institution | $425 |
| SANOFI US SERVICES INC. · Gaucher Disease Registry Protocol · 2025 | Their institution | $399 |
| SANOFI US SERVICES INC. · Pompe Disease Registry · 2025 | Their institution | $266 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033539671
- Licence
- WA MD60654898Washington MD.MD.60654898: Expired
- Group
- UCSF Pediatrics Associates · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 1033539671
- Taxonomy
- Federal specialty code 207SG0201X (207SG0201X); Federal specialty code 207SG0202X (207SG0202X)
- Mailing address
- 1825 4th St Fl 6, San Francisco, CA, 94143
- NPI first listed
- 2014-04-22
- NPI last updated
- 2024-08-29
- NPI record certified
- 2024-08-29
This is when the NPI record was last certified, not a medical board exam.